VC Advantage
Health Care Venture Capital News from Healthcare Corporate Finance News
Written by: Gretchen Swanson, Editor of the Healthcare Corporate Finance News

FREE TRIAL TO THE
HEALTHCARE CORPORATE FINANCE NEWS!

Healthcare Corporate Finance News

First Name

Last Name

Company

Company Type

Address

Address2

City

State

ZipCode

Country

Email

Email (again, to verify)

Phone

Fax

To confirm this request please enter: blogv

Submission may take a few seconds. Please click only once.

Top 5 Health Care Venture Capital Deals (April 17, 2006)

During the period ended April 15, 2006, a total of $349.8 million in venture capital was raised by 18 health care companies, including Merrimack Pharmaceuticals, which raised $65 million in the largest round so far this month. Pharmaceutical companies announced the greatest amount of funding in one sector, with four deals totaling $94 million, but there were more deals announced by biopharmaceutical companies, with six deals totaling $88 million.

BIOPHARMACEUTICALS
Date	Company	Amount	Round	Investors
4/12/2006	Novagali Pharma	$31.5 million		AGF Private Equity, 123 Multinova, Auriga Partners, CDC Entreprises Innovation, Credit Agricole Private Equity, Edmond de Rothschild Investment Partners, others
BIOTECHNOLOGY
4/3/2006	Merrimack Pharmaceuticals, Inc.	$65.0 million	E	Jennison Associates, Modal Capital, Noonday Assets Management, TPG-Axon Capital, others
MEDICAL DEVICES
4/11/2006	AngioScore, Inc.	$30.0 million	D	Telegraph Hill Partners (lead), QuestMark Partners, Psilos Group Management, UV Partners, California Technology Ventures, Innomed Ventures
PHARMACEUTICALS
4/11/2006	Xenon Pharmaceuticals Inc.	$31.0 million		MX Associates, LipoteRx Ltd. (co-leads)
4/10/2006	Hunter-Fleming	$27.0 million	B	MTI Partners, Advent International, ITX Corporation, Omega Fund Management, Pharmabio Development, Finance South West Growth Fund

Click here for a FREE TRIAL to the Healthcare Corporate Finance News

VC Blog Archive